摩洛哥重症 COVID-19 ICU 患者的 TYK2、IFITM3、IFNAR2 和 OAS3 单核苷酸多态性。

IF 3.5 3区 医学
R Benmansour, M R Tagajdid, H El Hamzaoui, S Fjouji, N Doghmi, A Houba, I Belbacha, S Elkochri, R Aabi, H Elannaz, A Laraqui, B El Mchichi, T Chmitah, N Touil, K Ennibi, R Eljaoudi, E Elmir, I Amine Lahlou, H Oumzil
{"title":"摩洛哥重症 COVID-19 ICU 患者的 TYK2、IFITM3、IFNAR2 和 OAS3 单核苷酸多态性。","authors":"R Benmansour, M R Tagajdid, H El Hamzaoui, S Fjouji, N Doghmi, A Houba, I Belbacha, S Elkochri, R Aabi, H Elannaz, A Laraqui, B El Mchichi, T Chmitah, N Touil, K Ennibi, R Eljaoudi, E Elmir, I Amine Lahlou, H Oumzil","doi":"10.1177/03946320241257241","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to explore the potential correlation between specific single nucleotide polymorphisms (TYK2, IFITM3, IFNAR2, and OAS3 variants) and the severity of COVID-19 in Moroccan patients.</p><p><strong>Methods: </strong>A genetic analysis was conducted on 109 patients with PCR-confirmed SARS-CoV-2 infection in Morocco. Among these patients, 46% were hospitalized in the intensive care unit, while 59% were not hospitalized. Importantly, all patients lacked known risk factors associated with COVID-19 severity. Genotyping was performed to identify variations in TYK2 rs74956615, IFITM3 rs12252, IFNAR2 rs2236757, and OAS3 rs10735079. Statistical analysis was applied using codominant, dominant and recessive logistic regression models to assess correlations with COVID-19 severity.</p><p><strong>Results: </strong>Our findings revealed no significant correlation between TYK2 rs74956615, IFITM3 rs12252, IFNAR2 rs2236757, and OAS3 rs10735079 with COVID-19 severity in Moroccan patients, as indicated in logistic regression models (<i>p</i> > .05). Interestingly, these results may offer insights into the mitigated impact of the COVID-19 pandemic and the reduced severity observed in SARS-CoV-2 infected patients in Morocco. Age, however, exhibited a significant correlation with severity (<i>p</i> < .001), with a trend towards increased likelihood of ICU admission with advancing age. Additionally, In the severe group, a higher proportion of patients were females (54%), indicating a statistically significant correlation with disease severity (<i>p</i> = .04). Nevertheless, female ICU patients aged above 60 years accounted for 37%, compared to 17% for males.</p><p><strong>Conclusion: </strong>This study underscores the absence of a genetic association between the selected polymorphisms and COVID-19 severity in Moroccan patients. Advanced age emerges as the primary factor influencing the severity of COVID-19 patients without comorbidities. We recommend setting the threshold for advanced age at 60 years as a risk factor for severe forms of COVID-19.</p>","PeriodicalId":48647,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"38 ","pages":"3946320241257241"},"PeriodicalIF":3.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11102656/pdf/","citationCount":"0","resultStr":"{\"title\":\"TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.\",\"authors\":\"R Benmansour, M R Tagajdid, H El Hamzaoui, S Fjouji, N Doghmi, A Houba, I Belbacha, S Elkochri, R Aabi, H Elannaz, A Laraqui, B El Mchichi, T Chmitah, N Touil, K Ennibi, R Eljaoudi, E Elmir, I Amine Lahlou, H Oumzil\",\"doi\":\"10.1177/03946320241257241\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>This study aimed to explore the potential correlation between specific single nucleotide polymorphisms (TYK2, IFITM3, IFNAR2, and OAS3 variants) and the severity of COVID-19 in Moroccan patients.</p><p><strong>Methods: </strong>A genetic analysis was conducted on 109 patients with PCR-confirmed SARS-CoV-2 infection in Morocco. Among these patients, 46% were hospitalized in the intensive care unit, while 59% were not hospitalized. Importantly, all patients lacked known risk factors associated with COVID-19 severity. Genotyping was performed to identify variations in TYK2 rs74956615, IFITM3 rs12252, IFNAR2 rs2236757, and OAS3 rs10735079. Statistical analysis was applied using codominant, dominant and recessive logistic regression models to assess correlations with COVID-19 severity.</p><p><strong>Results: </strong>Our findings revealed no significant correlation between TYK2 rs74956615, IFITM3 rs12252, IFNAR2 rs2236757, and OAS3 rs10735079 with COVID-19 severity in Moroccan patients, as indicated in logistic regression models (<i>p</i> > .05). Interestingly, these results may offer insights into the mitigated impact of the COVID-19 pandemic and the reduced severity observed in SARS-CoV-2 infected patients in Morocco. Age, however, exhibited a significant correlation with severity (<i>p</i> < .001), with a trend towards increased likelihood of ICU admission with advancing age. Additionally, In the severe group, a higher proportion of patients were females (54%), indicating a statistically significant correlation with disease severity (<i>p</i> = .04). Nevertheless, female ICU patients aged above 60 years accounted for 37%, compared to 17% for males.</p><p><strong>Conclusion: </strong>This study underscores the absence of a genetic association between the selected polymorphisms and COVID-19 severity in Moroccan patients. Advanced age emerges as the primary factor influencing the severity of COVID-19 patients without comorbidities. We recommend setting the threshold for advanced age at 60 years as a risk factor for severe forms of COVID-19.</p>\",\"PeriodicalId\":48647,\"journal\":{\"name\":\"International Journal of Immunopathology and Pharmacology\",\"volume\":\"38 \",\"pages\":\"3946320241257241\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11102656/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Immunopathology and Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/03946320241257241\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Immunopathology and Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03946320241257241","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

研究目的本研究旨在探讨特定单核苷酸多态性(TYK2、IFITM3、IFNAR2 和 OAS3 变体)与摩洛哥患者 COVID-19 严重程度之间的潜在相关性:对摩洛哥 109 名经 PCR 证实感染 SARS-CoV-2 的患者进行了基因分析。在这些患者中,46%在重症监护室住院,59%没有住院。重要的是,所有患者都缺乏与 COVID-19 严重程度相关的已知风险因素。通过基因分型确定了 TYK2 rs74956615、IFITM3 rs12252、IFNAR2 rs2236757 和 OAS3 rs10735079 的变异。统计分析采用了共显、显性和隐性逻辑回归模型,以评估与 COVID-19 严重程度的相关性:结果:我们的研究结果表明,TYK2 rs74956615、IFITM3 rs12252、IFNAR2 rs2236757 和 OAS3 rs10735079 与摩洛哥患者 COVID-19 的严重程度无明显相关性,如逻辑回归模型所示(p > .05)。有趣的是,这些结果可能有助于了解 COVID-19 大流行对摩洛哥 SARS-CoV-2 感染者的影响减轻以及严重程度降低的情况。然而,年龄与严重程度有明显的相关性(p < .001),随着年龄的增长,入住重症监护室的可能性有增加的趋势。此外,在重症组中,女性患者的比例较高(54%),这表明女性患者与疾病严重程度存在统计学意义上的显著相关性(p = .04)。然而,60 岁以上的重症监护室女性患者占 37%,而男性患者仅占 17%:本研究强调,摩洛哥患者的所选多态性与 COVID-19 的严重程度之间不存在遗传关联。高龄是影响无合并症的 COVID-19 患者病情严重程度的主要因素。我们建议将高龄的阈值定为 60 岁,作为 COVID-19 严重型的风险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.

Objectives: This study aimed to explore the potential correlation between specific single nucleotide polymorphisms (TYK2, IFITM3, IFNAR2, and OAS3 variants) and the severity of COVID-19 in Moroccan patients.

Methods: A genetic analysis was conducted on 109 patients with PCR-confirmed SARS-CoV-2 infection in Morocco. Among these patients, 46% were hospitalized in the intensive care unit, while 59% were not hospitalized. Importantly, all patients lacked known risk factors associated with COVID-19 severity. Genotyping was performed to identify variations in TYK2 rs74956615, IFITM3 rs12252, IFNAR2 rs2236757, and OAS3 rs10735079. Statistical analysis was applied using codominant, dominant and recessive logistic regression models to assess correlations with COVID-19 severity.

Results: Our findings revealed no significant correlation between TYK2 rs74956615, IFITM3 rs12252, IFNAR2 rs2236757, and OAS3 rs10735079 with COVID-19 severity in Moroccan patients, as indicated in logistic regression models (p > .05). Interestingly, these results may offer insights into the mitigated impact of the COVID-19 pandemic and the reduced severity observed in SARS-CoV-2 infected patients in Morocco. Age, however, exhibited a significant correlation with severity (p < .001), with a trend towards increased likelihood of ICU admission with advancing age. Additionally, In the severe group, a higher proportion of patients were females (54%), indicating a statistically significant correlation with disease severity (p = .04). Nevertheless, female ICU patients aged above 60 years accounted for 37%, compared to 17% for males.

Conclusion: This study underscores the absence of a genetic association between the selected polymorphisms and COVID-19 severity in Moroccan patients. Advanced age emerges as the primary factor influencing the severity of COVID-19 patients without comorbidities. We recommend setting the threshold for advanced age at 60 years as a risk factor for severe forms of COVID-19.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Immunopathology and Pharmacology
International Journal of Immunopathology and Pharmacology Immunology and Microbiology-Immunology
自引率
0.00%
发文量
88
期刊介绍: International Journal of Immunopathology and Pharmacology is an Open Access peer-reviewed journal publishing original papers describing research in the fields of immunology, pathology and pharmacology. The intention is that the journal should reflect both the experimental and clinical aspects of immunology as well as advances in the understanding of the pathology and pharmacology of the immune system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信